Ezra M. Friedberg, Director at Pelthos Therapeutics Inc. (PTHS), sold 283 shares at $27.12 ($8K) on 2026-06-15, disclosed to the SEC on 2026-06-17.
Scheduled sale ($8k) by Director under a pre-arranged 10b5-1 plan. Pre-set trade — not a discretionary signal on the stock.
Negative factors outweigh the positive ones.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $27.12 | 224 | $6K | 78.7% |
| 2 | $27.94 | 59 | $2K | 21.3% |
| Total | $27.29 avg | 283 | $8K | 100% |
| Filing → |
| PTHS | SELL | 2025-11-26 | $280K | — | Filing → |
| CHRO | BUY | 2024-03-12 | $100K | — | Filing → |